MedTrace Logo

Investigating the Impact of a Shared Decision-Making Tool

NCT05411939 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2024-01-18

No results posted yet for this study

Summary

The purpose of this research study is to learn more about how the use of a Shared Decision-Making Tool (SDMT) will impact a patient's decision-making to pursue treatment for knee osteoarthritis.

Conditions

  • Osteoarthritis, Knee

Interventions

OTHER

Shared Decision-Making Tool

The Shared Decision-Making Tool (SDMT) is designed to provide a personalized, patient- centered framework for clinical discussions regarding treatment options for knee osteoarthritis. The tool functions through patient input of information such as pain severity and current symptoms, alongside other demographic information such as age, race, and comorbidities, to offer a series of outcomes to better illustrate how the patient's specific disease presentation will progress. Ultimately, using the SDMT may impact patient behavior if patients change their treatment preferences after utilizing the tool. This can empower them to seek additional support over time and maintain communication with their orthopedist to ensure they are on a healthier path.

OTHER

Video

Short video that describes knee osteoarthritis and possible treatment options.

OTHER

Standard of Care

Standard of care counseling for a patient presenting with knee osteoarthritis.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Daniel H Wiznia, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-15
Primary Completion
2023-09-20
Completion
2023-09-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05411939 on ClinicalTrials.gov